therascreen® BRAF V600E RGQ PCR Kit by QIAGEN

Manufacturer QIAGEN

For qualitative detection of V600E mutations in the BRAF gene using real-time PCR


therascreen® BRAF V600E RGQ PCR Kit by QIAGEN product image
therascreen® BRAF V600E RGQ PCR Kit
Request Pricing

Receive your quote directly from the manufacturer.



0 Scientists have reviewed this product


Write the First Review

No Reviews

The therascreen BRAF V600E RGQ PCR Kit is a qualitative in vitro diagnostic test for the detection of V600E mutations in the BRAF gene. The test analyzes DNA extracted from formalin-fixed, paraffin-embedded (FFPE) tumor tissue, taken from a patient with colorectal cancer (CRC). It is intended to aid clinicians in identifying metastatic colorectal cancer (mCRC) patients eligible for treatment with BRAFTOVI (encorafenib) in combination with cetuximab.

Features

  • FDA-approved BRAF mutation companion diagnostic test
  • Reliable detection of V600E mutations in the BRAF gene
  • High sensitivity and specificity
  • Simple workflow from sample to insight
  • Automated data analysis using Rotor-Gene AssayManager for fast, easy result determination

Product Overview

therascreen® BRAF V600E RGQ PCR Kit by QIAGEN product image

therascreen® BRAF V600E RGQ PCR Kit

Manufacturer QIAGEN

Be the first to review this product